Metabolic Bulk Volume is an independent prognostic factor and facilitates identifying high risk cases for DLBCL patients treated with the R-CHOP
• Please read through all the templates before choosing • Pick the most relevant text template(s) from the following page and delete all others.• Edit the text as necessary, ensuring that the original incorrect text is included for the record, please see the below.• Please do not use any extra formatting when editing the templates, and only modify the red text unless absolutely necessary • Submit to Frontiers following the instructions on this page.When the original text contained incorrect information, to preserve the scientific record, please include that text when editing the below templates. For example:There was a mistake in the Funding statement, an incorrect number was used. The correct number is "2015C03Bd051.". The publisher apologizes for this mistake.The original version of this article has been updated.Last Name author1 et al.The original version of this article has been updated.There was a mistake in figure 5 The original version of this article has been updated.The original version of this article has been updated.There was a mistake in the caption of table 4 as published. The title of
Authors
- Yuxiao Hu
- Panpan Luan
- Silu Cui
- Qi Jiang
Institutions
- Nanjing University of Chinese Medicine (CN)
- Jiangsu Cancer Hospital (CN)
- Jiangsu Province Hospital (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2026-03-13
- DOI
- https://doi.org/10.3389/fonc.2026.1811308
- Primary Topic
- Venous Thromboembolism Diagnosis and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00